Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharma
Kidney transplantation in Lupus Nephritis: a comprehensive review of challenges and strategies. (PubMed, BMC Surg) - Mar 23, 2025 - "RECENT FINDINGS: Advancements in immunosuppressive therapies, including calcineurin inhibitors, Voclosporin, and biologic agents such as belimumab, have significantly improved LN management. Current guidelines emphasize the importance of achieving disease quiescence before transplantation, while new evidence supports the benefits of preemptive transplantation and personalized immunosuppressive regimens in improving patient and graft survival. This review highlights the latest evidence and strategies for optimizing kidney transplantation outcomes in LN patients, focusing on timing, immunosuppression, and disease monitoring." 
Journal • Review • Chronic Kidney Disease • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Systemic Lupus Erythematosus • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/40121458
 
Dan Pu; Jie Guo; Kerong Jiang; Lijuan Shi; Minfeng Bai; Ming Li; Xiaoliang Xu; Xiaqiong Gong; Yongsheng Pan
 
Mar 23, 2025
 
Prev Next